A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

October 28, 2027

Study Completion Date

October 28, 2028

Conditions
Relapsed/Refractory Non-Hodgkin Lymphoma
Interventions
DRUG

BMS-986458

Specified dose on specified days.

DRUG

Rituximab

Specified dose on specified days.

DRUG

Glofitamab/Obinutuzumab

Specified dose on specified days

DRUG

Mosunetuzumab

Specified dose on specified days

Trial Locations (33)

1205

RECRUITING

Hopitaux Universitaires de Geneve (HUG), Geneva

4031

RECRUITING

University Hospital Basel, Basel

6500

RECRUITING

Ospedale Regionale Bellinzona e Valli, Bellinzona

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

11042

RECRUITING

Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success

13125

RECRUITING

Helios Klinikum Berlin-Buch, Berlin

15232

NOT_YET_RECRUITING

Local Institution - 0040, Pittsburgh

28009

NOT_YET_RECRUITING

Local Institution - 0069, Madrid

28040

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

31008

RECRUITING

Clinica Universidad de Navarra, Pamplona

31059

RECRUITING

Institut Claudius Regaud, Toulouse

32224

NOT_YET_RECRUITING

Local Institution - 0068, Jacksonville

33076

NOT_YET_RECRUITING

Local Institution - 0057, Bordeaux

33612

NOT_YET_RECRUITING

Local Institution - 0027, Tampa

34295

RECRUITING

CHU SAINT ELOI - Departement Hematologie Clinique, Montpellier

37007

RECRUITING

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca

45147

NOT_YET_RECRUITING

Local Institution - 0070, Essen

48149

RECRUITING

Universitätsklinikum Münster - Albert Schweitzer Campus, Münster

53226

NOT_YET_RECRUITING

Local Institution - 0024, Milwaukee

55905

NOT_YET_RECRUITING

Local Institution - 0066, Rochester

59000

RECRUITING

Hopital Claude Huriez - CHU de Lille, Lille

66205

NOT_YET_RECRUITING

Local Institution - 0014, Fairway

66424

RECRUITING

Universitaetsklinikum des Saarlandes, Homburg

75010

NOT_YET_RECRUITING

Local Institution - 0058, Paris

85054

NOT_YET_RECRUITING

Local Institution - 0067, Phoenix

91010

RECRUITING

City of Hope Comprehensive Cancer Center, Duarte

94800

RECRUITING

Gustave Roussy, Villejuif

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

04103

RECRUITING

Universitätsklinikum Leipzig, Leipzig

6229 HX

RECRUITING

Maastricht UMC+, Maastricht

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06090539 - A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas | Biotech Hunter | Biotech Hunter